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ABSTRACT
The human salivary gland (SG) has an elegant architecture of epithelial acini, connecting ductal
branching structures, vascular and neuronal networks that together function to produce and secrete
saliva. This review focuses on the translation of cell- and tissue-based research toward therapies for
patients suffering from SG hypofunction and related dry mouth syndrome (xerostomia), as a conse-
quence of radiation therapy or systemic disease. We will broadly review the recent literature and
discuss the clinical prospects of stem/progenitor cell and tissue-based therapies for SG repair and/
or regeneration. Thus far, several strategies have been proposed for the purpose of restoring SG
function: (1) transplanting autologous SG-derived epithelial stem/progenitor cells; (2) exploiting non-
epithelial cells and/or their bioactive lysates; and (3) tissue engineering approaches using 3D (three-
dimensional) biomaterials loaded with SG cells and/or bioactive cues to mimic in vivo SGs. We pre-
dict that further scientific improvement in each of these areas will translate to effective therapies
toward the repair of damaged glands and the development of miniature SG organoids for the fun-
damental restoration of saliva secretion. STEM CELLS 2017;35:97–105
SIGNIFICANCE STATEMENT
This review covers recent advances in translating cell-based research toward pre-clinical thera-
pies. We focus on salivary gland (SG) loss-of-function and subsequent dry mouth syndrome as
caused by radiation therapy or systemic disease, although the described concepts can be trans-
lated to other injured somatic tissues. Proposed therapies include implantation of autologous
tissue-specific stem/progenitor cells, non-tissue specific cells and/or their bioactive lysates
(secretome); and organoid-like constructs created by cells in the presence or not of bioactive
cues and three-dimensional biomaterials. These emerging approaches to repair damaged SGs
are discussed herein, and evaluated on their success to restore native tissue architecture, epi-
thelial cell polarization, ductal branching, lumen formation, directionality of secretory flow, and
clinically relevant tissue functionality.
INTRODUCTION
A Place for Cell-Based Therapies
Irreversible SG hypofunction and its associated
symptoms, termed xerostomia, are a hallmark
of several systemic diseases, such as Sj€ogren’s
syndrome, granulomatous diseases, graft-
versus-host disease, cystic fibrosis, uncon-
trolled diabetes, human immunodeficiency
virus infection, thyroid disease, and late-stage
liver disease [1]. Hyposalivation is also the
most significant long-term complication for
more than 550,000 patients that are annually
diagnosed with head and neck cancer (HNC)
globally and for whom radiation therapy (RT)
is the main treatment [2–4]. Saliva is required
for digestion, lubrication, oral homeostasis and
protection against a variety of microbial and
environmental hazards. Thus, a lack in saliva
production can cause various life-disrupting
pathological events. Rampant caries, painful
mucositis, oral fungal infections, taste loss,
speech deficits, and difficulty in swallowing are
just a few examples of events that greatly
impair patients’ oral and systemic health [3].
Current preventative therapies, such as
surgical SG relocation outside the radiation
field [5] or use of free radical scavengers [6]
are challenging or not always effective. Using
advanced SG-sparing intensity-modulated radi-
ation therapy (IMRT) can still result in xerosto-
mia, even though partial improvement of
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TRANSLATIONAL AND CLINICAL
RESEARCH
salivary secretion may occur [2, 3, 7]. This functional outcome
of IMRT is correlated to each HNC patient’s personalized radi-
ation treatment plan that all or not may affect specific regions
harboring epithelial stem/progenitor cells [8] and its unique
environment.
The epithelial compartment of SGs consists of nearly 80%
saliva secreting acinar and 20% saliva transporting/modifying
ductal cells. When SGs are in the radiation field, radiation dam-
age occurs to these epithelial cells as well as surrounding blood
vessels and nerves [4, 9]. While radiation-induced leakage of
granules was long considered to be the cause of acute loss of
saliva secretion, it couldn’t fully explain why proteolytic enzyme
leakage was not accompanied with immediate epithelial cell
loss [10]. Main causes of acute radiation damage were later
credited to disturbed signal transduction pathways on the cell
membrane. Irreversible damage to muscarinic receptor stimu-
lated watery secretion [11] and dysfunction in water channels
like Aquaporin 5 [12] more likely explain the high and early
radiosensitivity effects. Thereafter, late to very late RT glandular
dysfunction responses are due to parenchymal cell loss by apo-
ptosis, and varying degrees of inflammation and fibrosis [10].
Even though most ductal epithelia remain morphologically, it is
clear that their cellular function is impaired to some extent
after RT, based on the reported decrease in protein expression
of signaling receptors and structural cytokeratins [13]. Late-
response effects further correlate with damage to the sur-
rounding microenvironment by noticeable blood vessel dilation
and function loss [14]. More recently, reduced parasympathetic
nervous function was also suggested to be part of late post-RT
effects [15, 16]. As nerves and blood vessels aid in epithelial
cell repair post-RT, the combined radiation damage to acini,
ducts, nerves and blood vessels, and development of fibrosis
further obstructs normal gland regeneration (Fig. 1) [4].
The use of artificial saliva substitutes provides temporary
relief of xerostomia [4], and the administration of systemic
sialogogues such as Pilocarpine increases saliva secretion, but
their efficacy relies on the amount of remaining functional SG
cells [18]. As such, HNC patients with extensive SG damage
still await treatments to permanently restore salivary function.
Due to our improved understanding of tissue morphogenesis
and how (partially) damaged cells can be re-activated or
replaced, several cellular and tissue-based therapies have
been proposed to repair damaged SGs and/or generate new
SG tissues (Fig. 2) [19, 20]. Despite cellular differences within
the three major SGs (parotid, submandibular, and sublingual)
are present, predominantly in the ratio of serous and mucous
acini and potentially in their unique set of progenitors,
researchers mainly focused their SG regenerative studies on
submandibular and parotid glands. However, we propose that
the following therapies may be applicable to all major glands.
These can be grouped in the following categories:
Autologous epithelial stem/progenitor cell transplantation:
prior to RT, cells can be isolated from SG biopsies, potentially
in vitro cultured and cryopreserved during RT, and trans-
planted into the irradiated gland post-RT to replace function-
ally damaged and/or lost cells.
Application of non-epithelial specific cell types and/or
their bioactive lysates: (a) to trigger paracrine regenerative
effects on remaining SG cells after SG damage or (b) to gener-
ate new SG-specific cells or (c) transplant bioengineered SG
tissue into the gland space using cells cultured with biomate-
rials and/or growth factors.
These proposed therapies have been tested in rodent
models and recent outcomes will be highlighted in the follow-
ing sections. Despite cellular differences are present between
the three major SGs, we classified them
A VARIETY OF CELL-BASED THERAPIES TO CHOOSE FROM
Autologous Transplant of SG Epithelial Cells
As mentioned earlier, partial gland loss-of-function can in cer-
tain situations be spontaneously recovered post-IMRT [21].
This lead to the hypothesis that endogenous SG cells can par-
ticipate in organ repair, and thus that cell transplants could
potentially be useful to regenerate severe loss-of-function.
The first proof-of-concept study for transplanting autolo-
gous SG cells to increase salivary function was carried out in
rodents and used epithelial cells expressing the cell surface
receptor KIT (c-Kit, CD117). Only as few as 100–300 KIT1 cells
were required to generate new acinar and ductal structures
and to significantly improve organ function after radiation
[19]. This research demonstrated that mouse SGs contain cells
with stem/progenitor properties that when transplanted could
maintain themselves and differentiate into multiple special-
ized SG cell types.
Further studies using transplantation of murine KIT1 sub-
populations (KIT1 CD241, KIT1 CD49f1, KIT1 CD241
CD49f1, KIT1 CD241 SCA11), illustrated that KIT1 cells pos-
sess different levels of stem/progenitor activity, with KIT1
CD241 (CD49f1/SCA11) cells reported to be the most
potent [13, 22]. These cells are likely located within the major
ducts of the central SG region where the highest stem/pro-
genitor cell number resides [8]. Thus, KIT1 cells have poten-
tial for future cell therapy applications, particularly because
they are present in human SGs [23] and can be isolated and
cultured ex vivo [24]. A very recent ground-breaking study
[25] has further supported the clinical use of enriched KIT1
subpopulations. Researchers were capable of rescuing hyposa-
livation in an in vivo mouse model with at least 500 human
KIT1 SG cells per gland [25]. Moreover, regulators of the Wnt
pathway were found upregulated in the SG tissues post-
transplantation. The same research group showed earlier that
the activation of the Wnt pathway is essential to drive the
self-renewal of murine SG stem/progenitor cells in vitro [26].
Yet, the use of techniques such as genetic lineage tracing
in mice, the application of DNA labels to mark label-retaining
quiescent cells, in vitro floating sphere assays (or salispheres),
and two-dimensional (2D) or three-dimensional (3D) cultures
of both human and rodent SG cells revealed the existence of
multiple stem/progenitor-like cells in the SG. These stem/pro-
genitor cells can be identified and isolated based on the
expression of a set of proteins and/or enzymes, such as cell
surface receptors and cytokeratins (Table 1). Interestingly,
these stem/progenitor cells appear at different times during
organ development and may compensate for each other’s cell
loss to allow proper organ formation [49]. Even during adult
SG homeostasis, multiple reservoir cell types in compart-
ments, such as ducts and acini, harbor high mitotic capacity
and the ability to self-duplicate, that is, maintain and/or
expand themselves [36, 50, 51]. However, from studies on
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SGs and other branching organs (reviewed in [52, 53]), it
becomes clear that these compartmental reservoirs of stem/
progenitor cells that regulate homeostatic maintenance may
respond differently to tissue damage and/or become plastic
by contributing to a cell population they normally do not
form.
Thus, even though KIT1 cells as well as CD241/CD291
epithelial cells have been shown to restore hyposalivation in
vivo ([13, 19, 22, 54], we can not rule out that other cell types
are not able and/or are more potent to regenerate SGs. Table
1 summarizes different cell markers that were classified with
stem/progenitor potential, but majority were not fully tested
yet for their regenerative capacity in RT clinical settings.
Additionally, depending on the location and level of RT-
induced damage in the SG, different stem/progenitor cells
could potentially be used for repair. A recent study [8]
revealed that a specific region within the gland is more sensi-
tive to radiation than others, and that radiation to this area
reflects in severe saliva loss and tissue damage. When the
50% of cranial region of the SG was radiated, the entire gland
degenerated including the shielded caudal 50% [8]. In con-
trast, damage remained restricted to the 50% caudal region
when only this part was being radiated. This suggests that
once multipotent stem/progenitor cells, which are proposed
to be located in a cranial sub-volume, are lost other cell types
are not able to compensate and repair the gland [8]. Howev-
er, when cranial stem/progenitor cells remained unaffected
they were able to maintain this area of the gland functional.
As such, it now becomes speculative whether different cell
types could be used in each scenario. For example, while
transplantation of multipotent stem/progenitor cells becomes
preconditioned when the entire SG is damaged, less potent
cells and/or multiple compartmental reservoir cells could be
applied for local caudal SG repair [8]. Even acinar cells, which
were long assumed to be permanently differentiated and
post-mitotic, could now be considered for SG cell therapy as
they can self-duplicate after damage in post-duct ligation [36],
partial SG excision [55], post-chronic sialadenitis [56] and possi-
bly post-RT conditions to locally repair and maintain the secre-
tory compartment. Most interestingly, SG repair is not only
driven by transplanted cells, but also by the remaining endoge-
nous stem/progenitor cells [25]. Radiation can induce stem/
progenitor cell dormancy in vivo [41, 57], and thus these cells
can be locally activated with the appropriate stimuli. As such,
any type of transplanted epithelial cell could enhance local
endogenous repair if the appropriate stimuli are produced and
a dormant stem/progenitor cell is present nearby.
However, from a clinical standpoint there may be limita-
tions to autologous cell therapy since SGs from aging patients
contain fewer stem/progenitor cells [24, 58]. This implies that
more stem/progenitor cells (than those obtained in the pre-
RT biopsy) may be required for organ repair. Recent efforts to
increase the number of KIT1 cells ex vivo using growth fac-
tors [59] or Aldehyde dehydrogenase-3 (ALDH3) activator [28]
may be useful, although, the absolute cell number required
for functional regeneration of the human gland remains
unclear. Alternatively, non-SG cells may be considered to
address this limitation, as outlined below.
Figure 1. Different stages of damage in salivary glands evoked by radiation therapy (RT). (1) During salivary gland (SG) tissue homeo-
stasis, glands are innervated and vascularized to support the epithelial compartment that consists of ductal and acinar cells. (1) Upon
partial RT damage, parts of the gland are mild to moderately affected by RT (depending on the species), including the acinar compart-
ment. (3) When RT damage globally affects the SG, massive fibrosis with varying degrees of inflammation can be observed with exten-
sive loss in acinar and stem/progenitor cells. The irradiated glandular tissue is further marked by reduced endothelial function and
neuronal dysregulation. Abbreviations: RT, radiation therapy; SG, salivary gland.
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Another caveat in developing SG cell therapies could
potentially be the limited lifespan of biopsy-derived cells cul-
tured ex vivo. In such cases, methods to cryopreserve and
store these progenitors from biopsies have been developed.
Neumann and others [60] established a stem cell banking
model where SG CD49f1 CD291 cells were cryopreserved for
up to 3 years without affecting their genetic or functional sta-
bility, validating that cryopreservation could be part of a cell
therapy option in the near future.
In conclusion, multiple research groups have shown that
rodent SG-specific epithelial cell transplantation is a feasible
approach to repair irradiated SGs. Future research studies
will determine whether human SG cells behave in a similar
manner in ex vivo and in vivo assays [25]. Although success
has been achieved with epithelial KIT1 cells in rodents, cur-
rently, other more multipotent stem/progenitor cell candi-
dates and/or compartmental reservoir cells can be explored.
Alternatively, in clinical scenarios where autologous SG cell
numbers are low, we may need to take advantage of the
regenerative capacity of non-SG cells, as discussed in the
next section.
Nonepithelial Cell Types and Bioactive Lysates
There are many reports on the beneficial effects of non-SG
and/or non-epithelial cells to regenerate irradiated SGs. These
studies include Bone Marrow (BM)-derived cells [14, 61–63],
BM-derived mesenchymal stem cells (MSC) [64], human
adipose-derived MSCs [65–68], SG-derived MSC-like cells [32,
69], amniotic cells [70, 71], embryonic stem cells (ESC) [72],
and induced-pluripotent stem cells (iPS) [73].
Despite a proposed differentiation of BM-derived cells and
MSCs into SG acinar cells is observed in vitro, their actual
contribution to epithelial differentiation in vivo is not clear
and disputable. Their beneficial action may primarily occur via
paracrine pro-survival/proliferative effects on remaining epi-
thelial stem/progenitor cells and surrounding environmental
cells. For example, transplantation of G-CSF/FLT3/SCF-mobi-
lized BM-derived cells [14] not only improved saliva
Figure 2. Proposed therapies to regenerate radiated salivary glands (SGs). Different epithelial cell types are maintained during homeo-
stasis: ductal (intercalated, striated, granular convoluted tubule, and excretory), myoepithelial, and acinar cells. When glands are partially
or globally injured, epithelial cells can undergo apoptosis and/or become functionally damaged. (1a) Reservoir cells of acinar and ductal
compartments could then be transplanted post-radiation to locally repair the epithelia. (2a) Similarly, adipocytes, bone marrow (BM)-
derived cells, mesenchymal stem cells (MSC) and/or amniotic cells can be transplanted, mobilized or intravenously (i.v.) delivered to aid
in repair mechanisms. They can either participate in the formation of glandular cell types or stimulate radiation-surviving cells with their
cellular secretome. (1b) After global SG damage, transplantation of multipotent SG specific epithelial stem/progenitors were shown to
functionally and morphologically repair the tissue. (2b) Transplants of embryonic stem cells (ESC) and iPS (induced Pluripotent Stem
cells) have also been explored to replace lost glandular cell types. (3) When SG are resected, in vitro tissue engineered organoids can
be embedded in extracellular matrix and/or biomaterials and placed in the glandular bedding to connect with remaining tissue residues.
Abbreviations: BM, bone marrow; MSC, mesenchymal stem cells; ESC, embryonic stem cells.
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production by inducing epithelial repair but also increased
microvessel density, which consequently led to better blood
perfusion. Similarly, adipose-derived MSCs diminished acinar
cell apoptosis as well as reduced fibrosis [67], and both BM-
MSC as SG-derived mesenchymal-like cells exerted immuno-
suppressive activities [69].
The beneficial potential of these paracrine effects led
investigators to explore the addition of the bioactive compo-
nents, also called “soup,” secreted by these adipose and BM-
derived cells to repair SGs who underwent RT [43, 74]. The
exact content of the bioactive components remains elusive to
date, but several potential contributing signaling pathways
have been identified. Studies using systemic growth factor
delivery or genetic overstimulation of specific signaling path-
ways suggest that KGF (or FGF7) can increase stem/progenitor
cell numbers in vivo post-RT [41, 75]. A similar role was
attributed to WNT/b-catenin [47, 48] and Sonic Hedgehog
(SHH) signaling [42] in post-RT and post-ductal ligation set-
tings. Also treatment with EGF, IGF1, FGF2 [39, 40, 45], IL6
[44], ALDH3 [37], or EDA activators [38] reduced cell apopto-
sis and promoted proliferation (Table 1). Even post-radiation
treatment with hormone Melatonin can decrease oxidative
stress and lipid peroxidation in SGs [46]. Another putative
activator for inducing acinar differentiation may be the
NOTCH signaling pathway [76, 77], even though its beneficial
action in vivo post-RT has not been confirmed yet. All these
signaling factors are summarized in Table 1.
Since multiple factors (e.g., GM-CSF, VEGF, IL6, and IGF1)
are found in “soups,” the anti-apoptotic and pro-proliferative
cues can thus aid not only in epithelial but also in microenvi-
ronmental repair [43]. Moreover, intravenous “soup” adminis-
tration may be all that is required to clinically improve saliva
production as this delivery route appears to be as effective in
rodents [43]. However, it remains to be evaluated whether
the “soup” strategy will work as efficiently in every patient.
Similar to the clinical efficacy of Pilocarpine administration in
RT-induced xerostomia settings [78], the “soup” strategy relies
on the amount of remaining SG cells. Thus, clinical successes
will depend on the remaining cells that need paracrine
stimulation and whether these stimuli are present in the
“soup.” While angiogenic factors have been described to be
present in certain “soups,” it is not clear yet whether neuro-
trophic factors are. Neuronal cells, such as the ones from the
parasympathetic nervous system, aid in epithelial regeneration
post-RT [15, 22] and thus, if required, neurotrophic factors
such as Neurturin or Glial cell-Derived Neurotrophic Factor
could potentially be (co-)delivered to radiated SGs via retro-
grade ductal or intraglandular injections.
While BM-derived cells and MSCs might not efficiently dif-
ferentiate into SG cells, other pluripotent cell types such as
ESCs and iPS cells can be explored to provide new pools of
SG-specific cells. As such, SG secretory cells were already gen-
erated from ESCs [72]. This study used 3D co-culture of
mouse ESCs with a human SG-derived fibroblast environment
to initiate expression of SG-related markers. While the ESC-
derived SG-like cells survived post-RT SG transplantation, it is
still unclear whether they functionally regenerate the tissue
[72]. If these cells possess genomic stability and lack oncogen-
ic potential, both ESC [72] and iPS-derived SG cells [73] can
serve as an additional cell-based therapy.
Tissue Engineering Strategies to Generate Sg
Organoids
SG tissue engineering requires three essential components:
(1) cell-cell contacts; (2) cell contacts with extracellular matrix
(ECM) proteins, and (3) a biocompatible and biodegradable
3D scaffold that can hold these components together [79].
Many scaffolds have been proposed, which are porous
and either biologic (e.g., collagen, fibrin, silk, chitosan, algi-
nate, hyaluronic acid (HA)) in origin or synthetic biocompati-
ble biomaterials (e.g., poly-glycolic acid, poly-lactic acid, poly
lactic-co-glycolic acid (PLGA), and polyethylene glycol), and/or
mixture of both. Depending on its biodegradability, porosity,
stiffness and strength, scaffolds promote cell adhesion, migra-
tion, and/or differentiation [80]. Ideally, engineered scaffolds
should structurally and functionally resemble the native SG
ECM architecture (reviewed in [81]).
While there are many new scaffolds being generated,
researchers must implement aspects of SG organogenesis,
branching morphogenesis and homeostasis to initially form 3D
miniature tissues, termed organoids. A summary of currently
used human cell-based models with translational potential is
presented in Table 2.
A long-standing hurdle in the field has been the long-term
growth and maintenance of specific acinar cell protein expres-
sion, as well as their cell polarity and secretory function.
Monolayer cultures, that is, 2D culture, of primary acinar cells
cause loss of biological functions including, acinar-specific pro-
tein expression (a-amylase, cystatin C, transmembrane protein
16A—TMEM16A, sodium-potassium-chloride cotransporter—
NKCC1, and aquaporin 5—AQP5), granule formation, calcium
mobilization, transepithelial resistance, and polarized amylase
secretion after b-adrenergic receptor stimulation. Gaining con-
trol of these biological functions appears to be related to spe-
cific media components and ECM products. High calcium
concentrations (0.05 mM) provide optimal acinar growth and
maintenance of polarization [85], and without addition of
ECM proteins the maintenance of acinar cells and formation
of organoids will be limited. For example, pure amino acid
non-ECM containing PuraMatrix peptide hydrogels hardly
Table 1. Summary list of suggested stem/progenitor cell markers
and environmental signaling cues (cytokines, growth factors,
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maintained SG cells [86], but mucin-secreting cells were easily
grown for up to 1 month on natural fibronectin-coated silk
fibroin scaffolds. Interestingly, 3D scaffolding itself induced
seeded cells to produce significantly more native ECM compo-
nents than in 2D cultures, which further supports more
appropriate cell differentiation and polarization. The observa-
tion that parotid cell cultures were better maintained on
these silk fibers compared to submandibular cells also indicat-
ed that each gland cell-type might require a unique ECM-
coated scaffold.
It is also important to note that each ECM differently
impacts cell polarization, differentiation, lumenization, and
tight junction formation. PLGA nanofibers coupled with
laminin-111 and chitosan functional units demonstrated that
laminin-111 tends to promote mature SG epithelial tight junc-
tions and apico-basal polarization, but conversely, chitosan
antagonizes this process [87]. Encapsulating human SG cells in
human-compatible HA hydrogels with recombinant Perlecan
IV domain not only induced cell organization into proliferating
spheroid structures, but also formed larger acini-like struc-
tures with a central lumen that were maintained long-term in
vitro [88]. In cases where there is a reduction in the assembly
of tight junctions (ZO-1 expression) [89], which are needed
for uni-directional flow of saliva, one can overcome this by
generating lithographically-based micropatterning curved
“craters.” These craters mimic the physical structure of the
basement membrane, and thus increased surface area
allowed for better apico-basal polarization and differentiation
of SG epithelial cells [90].
Apart from generating and maintaining proper cell types,
engineered SGs further require formation of branching struc-
tures. Chitosan appears to facilitate SG branching by
regulating production of basement membrane components
[91], and small branching organoids could also be formed in
Collagen type I and/or Matrigel [19, 24, 25, 31, 82, 83, 92].
While many positive results were obtained with Matrigel, its
components are not xeno-free as it contains basement mem-
brane proteins secreted by mouse sarcoma cells, and there-
fore, its use is not consistent with current Good
Manufacturing Practice regulations by the US Food and Drug
Administration (FDA). One alternative is to use the native
organ-specific ECM that can be obtained by decellularizing tis-
sues with detergents and then reseeding primary cells onto
the gland ECM structure, as accomplished for the rat subman-
dibular SG [93].
Recent advances have also been directed to develop more
functional organoids. These efforts include combinations of
linked ECM peptides and the development of controlled drug
or growth factor releases from scaffolds. These can then be
seeded with cells to direct differentiation and branching, with
or without various SG cell types. A current challenge remains
to let bioengineered tissues grow in size and properly connect
with remaining cells in the transplanted area. Efforts toward
this goal have recently been initiated in a mouse and rat
model [84, 94]. HA-gels with primary human cells were main-
tained and responded to neurotransmitters when integrated
in the area of resected parotid glands in immune compro-
mised rats [95]. An alternative approach showed that fetal SG
cells, both epithelium and mesenchyme, within a 3D Collagen
environment could be transplanted into the space of
completely resected SGs. Interestingly, a suture thread was
used to provide guidance for the primary duct to reconnect
with the oral cavity. Future efforts will certainly be directed
to using a similar approach with adult cells. Whether a similar
Table 2. Human cell-based therapy models already tested for the development of salivary gland 3D tissue organoids







 In vitro formation of functional
and differentiated salivary
components containing amylase
producing acinar-like cells and
ductal structures
 No in vivo studies
 Xenogeneic biomaterials
not suitable for clinical translation






 In vitro differentiation ability of
hSG progenitors into epithelial-
like acinar and ductal cell types
 In vitro long-term self-renewal
ability.
 No in vivo studies
 Xenogeneic biomaterials not
suitable for clinical translation







 In vitro 3D organization and
differentiation of hSG cells into
salivary cells with amylase-
producing acinar components
 No in vivo studies
 Xenogeneic biomaterials not
suitable for clinical translation





 HA hydrogel supported in vivo
lumen formation
 Supported viability and salivary
phenotypic features of hSG
progenitors in in vitro long-term
cultures
 No evaluation of salivary flow [84]
hSG primary cells




 Matrigel supported in vitro
expansion in long-term cultures
 3D xenogeneic matrix supported
differentiation of primary cells
 Injected hSG primary cells
(>500/gland) induced functional
rescue




not suitable for clinical translation
[25]
Abbreviation: hSG, human salivary gland.
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reconnection with the remaining duct can be obtained in
humans remains to be determined.
FUTURE PROSPECTS
Remarkable progression has been made in the last decade,
but a definitive therapy for SG hypofunction has not been
developed due to intrinsic challenges that come with each
approach. An underlying challenge is comparison of the ani-
mal models with human SGs. The biological differences
between human and rodent SGs and understanding how they
respond to RT requires further study but initial important
steps have been taken [25]. Moreover, potential differences in
development and/or regenerative strategies between the dif-
ferent glands (e.g., parotid, submandibular, sublingual) need
to be considered for future clinical translations. Also compli-
cating matters is the variation of RT damage that occurs in
individual patients with respect to both the location and dose
of RT as well as the patient’s age. However, with each discov-
ery in the future, a range of precision medicine therapies may
become available individualized to each patient. An apprecia-
tion of the strengths and limitations of each strategy as well
as whether the patients have existing RT damage will deter-
mine what therapy will be designed and delivered.
Theoretically, there should be no shortage of cell types, as
both SG-specific as non-SG specific cells could be used to
repair the epithelial compartment and surrounding microenvi-
ronment. The paracrine effects of each cell type will aid in
the repair process post-RT, and with the development of bio-
active scaffolds, we should be able to generate branching SG
organoids in the near future.
LIST OF ABBREVIATIONS
SG, salivary gland; RT, radiation therapy; HNC, head and neck
cancers; 3D, three-dimensional; 2D, two-dimensional; KRT,
cytokeratin; FGFR2b, fibroblast growth factor receptor 2b;
ALDH3, aldehyde dehydrogenase-3; BM, bone marrow; MSC,
mesenchymal stem cell; BMSC, bone marrow stem cell;
BM-MSC, bone marrow-derived stem cell; BM-cMSC, bone
marrow clonal mesenchymal stem cell; SMG, submandibular
gland; FGF, fibroblast growth factor; GM-CST, Granulocyte-
macrophage colony-stimulating factor; Flt3, Fms-Related
Tyrosine Kinase 3; SCF, stem cell factor; KGF, keratinocyte
growth factor; VEGF, vascular endothelial growth factor; IL6,
interleukin 6; IGF1, insulin-like growth factor 1; ESC, embryonic
stem cells; iPS, induced pluripotent stem cells; PLGA, poly-
(lactic-co-glycolic acid); HA, hyaluronic acid; ECM, extracel-
lular matrix.
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